Currently, Ozempic remains atop the other GLP-1 drugs on this list, but the drug has been available for longer. As the other drugs on this list become more prominent in the healthcare industry ...

Natural supplements have “very mild effects” on weight loss based on what Dr. Ali has seen. There is some data to suggest ...

This analysis finds that 57.4 million adults under the age of 65 could potentially be eligible for GLP-1 drugs based on ...

The demand for medications like Ozempic continues to cause shortages for both those seeking weight loss and patients with ...

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.

A large swath of insured Americans could be eligible for a popular class of weight loss and diabetes drugs. Meanwhile, Apple ...

While drugmakers Novo Nordisk and Eli Lilly assert that shortages of popular weight loss and diabetes medications Wegovy, Ozempic, Mounjaro and Zepbound are easing, many patients continue to face ...

Novo Nordisk’s weekly GLP-1 diabetes drug Ozempic has been included in formularies ... According to Reuters, Ozempic has been included on a 2018 formulary list of acceptable medicines drawn ...

Starting price of $149 offers improved accessibility compared to market prices of brand-name medications which can be 8x ...

The popularity of the newest weight loss medications has employers reevaluating their health plans. There are a lot of unknowns, but here’s what we do know based on the data.

The plaintiffs' attorneys claim that GLP-1 drugs — specifically Ozempic ... the litigation against the pharmaceutical giants, 85% list gastroparesis as an alleged injury. Gastroparesis occurs ...